ArticleActa diabetologica2026
Interpretable single-cell machine learning identifies PINK1-centred mitophagy as a determinant of metabolic fitness in type 2 diabetes.
Article in Acta diabetologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundProgressive pancreatic β-cell dysfunction constitutes a hallmark of type 2 diabetes (T2D), yet the molecular programmes governing metabolic fitness deterioration remain incompletely characterised at single-cell resolution.
methodsSingle-cell transcriptomic data (GSE221156) encompassing pancreatic islet cells from 48 donors (non-diabetic [ND], n = 17; pre-diabetic [PD], n = 14; T2D, n = 17) were analysed using an interpretable machine learning framework that integrated sparse rule-based classification, pathway-constrained modelling, and mitochondrial fitness indexing.
resultsFive transcriptionally distinct β-cell subtypes (β1-β5) were resolved. The β1 subtype exhibited peak proportional representation in PD donors (35.0%) compared with ND (16.7%) and T2D (21.1%), consistent with stress-induced adaptive expansion. Mitochondrial biogenesis and ER stress emerged as the top-ranked programmes discriminating T2D from ND β-cells (importance scores = 0.329 and 0.329). Within the mitophagy gene set, MFN2 exhibited the highest feature importance (|logFC| = 0.472), followed by PINK1 (|logFC| = 0.199). PINK1 expression progressively declined across β1→β5 subtypes. A mitochondrial fitness index integrating mitophagy, proteostasis, biogenesis, and oxidative phosphorylation achieved R² = 0.65 against module-based quality scores. Hypergeometric enrichment analysis of differentially expressed genes between the adaptive β1 subtype and dysfunctional β2-β5 subtypes revealed significant enrichment of insulin secretion (p = 0.0019), endoplasmic reticulum stress (p = 0.0013), and oxidative phosphorylation (p = 0.045) pathways.
conclusionsPINK1-centred mitophagy represents a critical determinant of β-cell metabolic fitness in T2D, with implications for therapeutic strategies aimed at preserving islet function during disease progression.
Indexed as
Identifiers
42440097What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.